BioInnovation Institute (BII)

BII's mission is to empower scientists and entrepreneurs to translate scientific discoveries into innovative therapies and technologies. Its vision is to establish Denmark as a global leader in the life sciences industry. This is achieved through a multifaceted approach encompassing incubation, acceleration, and venture capital investment.

Key Activities and Programs:

BII's activities center around supporting companies across their entire lifecycle, from early-stage research to commercialization. These activities include:

• Incubation: Providing startups with access to state-of-the-art laboratory facilities, mentorship from experienced professionals, and a vibrant collaborative environment. This includes providing resources and infrastructure necessary to advance their research and development.

• Acceleration: Offering tailored support and guidance to companies ready to scale up their operations, including access to investment opportunities and business development expertise. This stage focuses on refining business models and preparing for market entry.

• Venture Capital Investment: BII actively invests in promising companies within its network, providing crucial capital to fuel growth and expansion. This financial support is coupled with strategic guidance to enhance the likelihood of success.

• Networking and Collaboration: BII facilitates connections among its residents, investors, industry partners, and academic institutions, fostering collaboration and knowledge sharing. This creates a synergistic environment where innovative ideas can flourish.

• Talent Development: BII contributes to the development of future leaders in the life sciences industry through training programs and mentorship opportunities.

Infrastructure and Resources:

BII operates from a purpose-built facility in Copenhagen, offering cutting-edge laboratory space, office areas, and shared resources to its resident companies. The institute provides access to advanced equipment and technologies, reducing the financial burden on startups and allowing them to focus on innovation.

Partnerships and Funding:

BII's success is underpinned by strong partnerships with Novo Nordisk Foundation, the Danish government, and other key players in the Danish life science ecosystem. This collaborative approach ensures a sustainable and impactful contribution to the industry.

Overall Impact:

BII has rapidly established itself as a significant player in the European biotech landscape, attracting talent and investment to Denmark. Its contributions extend beyond individual company success; it plays a vital role in strengthening the Danish life science ecosystem and driving innovation to address global health challenges.